Loading institutional data...
Loading institutional data...
Held by 951 of 5,944 reporting institutions (99th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
No trend data available for this metric.
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.14B 100.0% | $5.38B 100.0% | $9.62B 100.0% | $7.32B 100.0% | $3.33B 100.0% | $3.13B 100.0% | $3.59B 100.0% | $3.37B 100.0% | $3.07B 100.0% | $2.68B 100.0% |
| Cost of Revenue | $4.47B 87.0% | $5.31B 98.8% | $8.43B 87.7% | $4.25B 58.0% | $2.33B 70.0% | $2.13B 68.2% | $2.33B 65.0% | $2.16B 63.9% | $1.97B 64.0% | $1.71B 63.8% |
| Cost of Products | — | — | — | — | — | — | — | — | $1.96B 63.9% | $1.71B 63.7% |
| Gross Profit | $668.7M 13.0% | $62.5M 1.2% | $1.19B 12.3% | $3.07B 42.0% | $998.0M 30.0% | $994.9M 31.8% | $1.26B 35.0% | $1.22B 36.1% | $1.11B 36.0% | $970.3M 36.2% |
| Research & Development | $51.4M 1.0% | $86.7M 1.6% | $85.7M 0.9% | $72.0M 1.0% | $54.0M 1.6% | $59.2M 1.9% | $58.3M 1.6% | $70.1M 2.1% | $84.3M 2.7% | $80.5M 3.0% |
| Selling, General & Admin | $550.0M 10.7% | $618.0M 11.5% | $910.0M 9.5% | $524.1M 7.2% | $441.5M 13.3% | $429.8M 13.7% | $533.4M 14.9% | $446.1M 13.2% | $450.3M 14.7% | $353.8M 13.2% |
| Operating Income | -$367.1M -7.1% | -$1.78B -33.0% | $251.9M 2.6% | $2.47B 33.7% | $798.4M 24.0% | $505.8M 16.2% | $666.1M 18.6% | $911.5M 27.0% | $571.7M 18.6% | $601.0M 22.4% |
| Interest Expense | $207.7M 4.0% | $165.6M 3.1% | $116.1M 1.2% | $123.0M 1.7% | $61.5M 1.8% | $73.1M 2.3% | $57.7M 1.6% | $52.4M 1.6% | $115.3M 3.8% | $65.2M 2.4% |
| Other Income (Expense), net | $22.7M 0.4% | $178.3M 3.3% | $110.9M 1.2% | $86.4M 1.2% | -$603.3M -18.1% | -$59.2M -1.9% | -$45.5M -1.3% | -$64.4M -1.9% | -$9.5M -0.3% | -$20.5M -0.8% |
| Pretax Income | -$552.1M -10.7% | -$1.76B -32.8% | $246.7M 2.6% | $2.43B 33.2% | $133.6M 4.0% | $373.5M 11.9% | $563.0M 15.7% | $794.7M 23.5% | $446.8M 14.5% | $515.3M 19.2% |
| Income Tax Expense | $156.9M 3.1% | $87.1M 1.6% | $430.3M 4.5% | $390.6M 5.3% | $29.4M 0.9% | $54.4M 1.7% | $88.2M 2.5% | $144.8M 4.3% | $431.8M 14.1% | $96.3M 3.6% |
| Net Income | -$510.6M -9.9% | -$1.18B -21.9% | $1.57B 16.4% | $2.69B 36.7% | $123.7M 3.7% | $375.8M 12.0% | $533.2M 14.9% | $693.6M 20.6% | $54.9M 1.8% | $643.7M 24.0% |
| Per Share | ||||||||||
| EPS (Basic) | $-5.76 | $-11.20 | $13.41 | $22.97 | $1.07 | $3.53 | $5.03 | $6.40 | $0.49 | $5.73 |
| EPS (Diluted) | $-5.76 | $-11.20 | $13.36 | $22.84 | $1.06 | $3.52 | $5.02 | $6.34 | $0.49 | $5.68 |
| Weighted Avg Shares (Basic) | 117.7M | 117.5M | 117.3M | 117.1M | 115.8M | 106.4M | 105.9M | 108.4M | 110.9M | 112.4M |
| Weighted Avg Shares (Diluted) | 117.7M | 117.5M | 117.8M | 117.8M | 116.5M | 106.8M | 106.3M | 109.5M | 112.4M | 113.2M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Insufficient balance-sheet detail (needs retained earnings, working capital, equity).
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor; leverage rising year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
The dividend is comfortably covered — only 28% of free cash flow, leaving room to grow it and fund buybacks. Last year: $191M dividends + $0 buybacks = $191M returned on $692M FCF.
9 consecutive years of dividend increases · 3%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: -4%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $1.6B covers the $74M due within a year 21.8× over. Scheduled principal only (excludes interest & revolver draws). As of 2025-12-31 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Effective rate ~6.7% on $3.1B of debt.
Cash of $1.6B fully covers short-term debt of $74M.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
No current price collected.
No standout strengths flagged.
Where each multiple sits in its own 14-yr range
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 18.2× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 63.9 | 65.0 | 68.2 | 70.0 | 58.0 | 87.7 | 98.8 | 87.0 |
| Gross Profit | 36.1 | 35.0 | 31.8 | 30.0 | 42.0 | 12.3 | 1.2 | 13.0 |
| R&D | 2.1 | 1.6 | 1.9 | 1.6 | 1.0 | 0.9 | 1.6 | 1.0 |
| SG&A | 13.2 | 14.9 | 13.7 | 13.3 | 7.2 | 9.5 | 11.5 | 10.7 |
| Operating Income | 27.0 | 18.6 | 16.2 | 24.0 | 33.7 | 2.6 | -33.0 | -7.1 |
| Income Tax | 4.3 | 2.5 | 1.7 | 0.9 | 5.3 | 4.5 | 1.6 | 3.1 |
| Net Income | 20.6 | 14.9 | 12.0 | 3.7 | 36.7 | 16.4 | -21.9 | -9.9 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on ALB: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.